The NAD+ precursor landscape has never been more crowded — or more confusing. NMN, NR, niacinamide, and niacin all raise NAD+ but through different pathways, with different clinical evidence, costs, and side effect profiles. This guide cuts through the noise with a definitive 2026 comparison so you can make the right choice for your longevity protocol.
The Four Main NAD+ Precursors: Quick Overview
| Precursor | Pathway to NAD+ | Steps | Human evidence | Flush? | Cost/month (SGD) |
|---|---|---|---|---|---|
| NMN | Salvage / NMN | 1–2 | Growing (2020–2026) | None | 80–200 |
| NR (Nicotinamide Riboside) | Salvage via NR kinase | 2 | Strong (multiple RCTs) | None | 60–150 |
| Niacinamide (NAM) | Salvage via NAMPT | 2–3 | Limited longevity-specific | None | 10–25 |
| Niacin (Nicotinic Acid) | Preiss-Handler | 3–4 | Decades (cardiovascular) | Common | 10–30 |
NMN (Nicotinamide Mononucleotide)
NMN is the most direct NAD+ precursor after NADH itself. It enters cells via the Slc12a8 transporter (confirmed in mice, strongly suspected in humans) and converts to NAD+ in one step via NMNAT enzymes. The 2022 Washington University human trial by Dr Shin-ichiro Imai showed NMN significantly raises NAD+ in peripheral blood and improves muscle insulin sensitivity in postmenopausal women.
NMN is popular in Singapore’s longevity community for energy enhancement, cognitive sharpness, and as a foundation for anti-ageing stacks. Sublingual NMN (dissolved under the tongue) shows superior bioavailability over oral capsules and is the preferred delivery method for performance-focused users. Typical effective doses: 250–500mg/day.
NR (Nicotinamide Riboside)
NR (sold commercially as Tru Niagen by Chromadex and Niagen by others) has the most robust human clinical trial evidence of any NAD+ precursor. Multiple randomised controlled trials have confirmed NR safely and meaningfully raises blood NAD+ in humans at doses of 300–1,000mg/day. NR converts to NMN before becoming NAD+, making it one metabolic step less direct than NMN — but this has not been shown to meaningfully reduce effectiveness in practice.
NR is generally slightly less expensive than NMN in Singapore and has a longer track record of human safety data. For those who prioritise evidence depth over theoretical pathway efficiency, NR is often the more conservative and well-justified choice. Typical effective doses: 300–600mg/day.
Niacinamide (NAM — Nicotinamide)
Niacinamide (also called nicotinamide) is the amide form of vitamin B3 and one of the cheapest NAD+ precursors available. It raises NAD+ via the salvage pathway through NAMPT — the rate-limiting enzyme in NAD+ biosynthesis. However, at high doses, niacinamide also inhibits sirtuins (the longevity proteins that NAD+ activates), potentially counteracting some of the longevity benefits you’re trying to achieve.
For longevity applications, niacinamide is generally not the preferred choice at high doses due to sirtuin inhibition. Low-dose niacinamide (25–100mg) as part of a skin health or mild NAD+ support protocol is reasonable, but for full NAD+ restoration, NMN or NR are superior options. Niacinamide does not cause flushing.
NMN vs NR: Which Is Better?
This is the most common question among Singapore’s longevity community. The honest answer: both work, and the difference in practical outcomes between NMN and NR at equivalent doses is likely small for most people.
Choose NMN if: you prioritise the most direct biochemical pathway, want sublingual delivery for enhanced bioavailability, are focused on muscle and cognitive performance, or are following a Dr David Sinclair-inspired protocol.
Choose NR if: you want the most extensively studied precursor with the strongest human clinical trial evidence, prefer a slightly lower price point, or have cardiovascular concerns where NR’s additional evidence base is reassuring.
NMN vs Niacinamide: Key Differences
NMN and niacinamide (NAM) both raise NAD+ but work through different sub-pathways. The critical difference is that high-dose niacinamide inhibits SIRT1 and other sirtuins — the very longevity proteins that elevated NAD+ is meant to activate. NMN does not have this inhibitory effect at therapeutic doses. For longevity purposes, NMN is strongly preferred over niacinamide at equivalent doses.
An important nuance: niacinamide at low doses (25–50mg) is used beneficially in some skin health protocols (reducing transepidermal water loss, improving barrier function) and does not cause the sirtuin inhibition seen at higher doses. Context matters significantly for niacinamide.
The NAD+ Stack: Combining Precursors
Some longevity physicians in Singapore recommend combining precursors to target multiple NAD+ biosynthesis pathways simultaneously. A common protocol used in high-performance longevity programmes:
- Morning: NMN 250–500mg (sublingual) + Resveratrol 500mg (to activate SIRT1)
- Evening: NR 300mg or low-dose niacin 50–100mg (to cover the Preiss-Handler pathway)
- Co-factors: TMG (Trimethylglycine) 500mg to prevent methyl group depletion from high-dose NAD+ precursors
At Lifespan Asia, we assess baseline NAD+ levels (via whole blood NAD+ testing where available) before recommending any specific precursor protocol. This biomarker-driven approach prevents guesswork and ensures the right compound is used for your specific metabolic profile.
NAD+ Precursor Trends 2026: What’s New
The 2025–2026 landscape has seen several important developments in NAD+ precursor research. A 2025 meta-analysis confirmed NR’s safety across 18 human trials with no serious adverse events at doses up to 2,000mg/day. A 2026 Nature Metabolism paper highlighted the importance of TMG co-supplementation with high-dose NAD+ precursors to prevent methylation pathway disruption. Meanwhile, next-generation NAD+ precursors including reduced NMN (NMNH) and NARH are entering early clinical testing with potentially superior bioavailability profiles.
Frequently Asked Questions
Is NMN or NR better for longevity?
Both NMN and NR effectively raise NAD+ and are safe at recommended doses. NMN is one step more direct in the pathway to NAD+ and is preferred by some longevity researchers. NR has a larger body of published human clinical trials. In practice, the difference for most users is likely small — choose based on your budget, delivery preference, and specific health goals.
Is niacinamide the same as NMN?
No. Niacinamide (nicotinamide) and NMN (nicotinamide mononucleotide) are different molecules. NMN is metabolically “upstream” of niacinamide — NMN converts more directly to NAD+. High-dose niacinamide can inhibit sirtuins, while NMN does not. For longevity purposes, NMN is the preferred choice between the two.
Should I take TMG with NMN or NR?
Yes, this is increasingly recommended by longevity physicians. High-dose NAD+ precursors increase the demand on your methylation pathways. TMG (trimethylglycine, also called betaine) provides methyl groups to compensate. A common dose is 500–1,000mg TMG daily with NMN or NR supplementation.